Register now at: https://strongbody.ai/aff?ref=0NJQ3DJ6
In the quiet suburbs of Arlington, Virginia, just outside Washington DC, on a mild October morning in 2025, Robert Thompson sat at his oak dining table with a fresh cup of coffee from the local Starbucks on Wilson Boulevard, his laptop open to the Multime AI app while his wife Sarah prepared breakfast for their two teenage sons in the kitchen behind him. At 52, Robert had been managing stage II prostate cancer for eighteen months after diagnosis at Inova Fairfax Hospital, following a routine PSA screening that had jumped from 3.2 to 8.7 in one year. His local oncologist at the hospital’s cancer center in Falls Church had prescribed a standard hormone therapy protocol plus six rounds of radiation, yet Robert often felt he was one step behind the latest global advances—new immunotherapy combinations reported in Europe and Asia that his US doctor mentioned only in passing during rushed follow-up visits every three months. That morning, as he opened the Global News Hub section in the Multime AI app for his daily five-minute scan, the top story caught his eye: a breakthrough Phase III trial from the University of Oxford in the UK showing a new PD-1 inhibitor combined with a low-dose CAR-T cell therapy had pushed remission rates from 42 percent to 78 percent in men with similar Gleason scores to his own 7. The article included direct links to the published Lancet Oncology data and patient testimonials from a London clinic. Without hesitation, Robert tapped the share button inside the app and sent the full article straight into the private group chat of his Personal Care Team on StrongBody AI.
The team—Dr. Elena Vargas, an oncologist based in Madrid, Spain, matched through the platform’s smart matching engine because her documented outcomes overlapped Robert’s exact interest tags in Oncology and Lifestyle Medicine; Dr. Michael Chen, a urologist in Singapore whose profile listed 214 US clients with identical hormone-resistant cases; and Dr. Priya Sharma, a immunotherapy specialist in Mumbai, India—received the article instantly. Dr. Vargas replied first with a voice note that played in clear English through the app’s translation engine while Robert’s sons finished their cereal at the table. “Robert, I just read the Oxford trial you shared. The PD-1 plus CAR-T data aligns perfectly with your current PSA trend of 4.1 after radiation. I can prepare an updated Offer right now to integrate a similar low-dose protocol using the approved biosimilar available through our partnered clinic in Virginia—let’s discuss the exact dosing so you stay ahead of the curve.” Robert’s heart rate, visible on his Apple Watch, dropped from 92 to 68 as he listened. He recorded a quick voice reply right there at the dining table: “Dr. Vargas, yes—my local doctor in Falls Church hasn’t mentioned this yet. Can we make the Offer include the exact monitoring schedule and the pharmacy in Arlington where I can pick up the supporting supplements you recommended last month?”
Within twenty minutes Dr. Vargas sent the custom Offer directly inside the group chat. “Updated Immunotherapy Integration Protocol – four-week add-on to your existing hormone therapy, including weekly voice check-ins, PSA tracking template, and biosimilar prescription guidance for the Arlington-area compounding pharmacy on Columbia Pike for $320 total, platform buyer fee already displayed transparently.” The Offer listed every deliverable with clinical precision: Week 1 bloodwork coordination with Inova Fairfax lab results uploaded via chat; Week 2 low-dose infusion schedule at a partnered outpatient center in Tysons Corner; daily voice notes from Dr. Vargas explaining side-effect management based on the exact Oxford trial data Robert had shared; and a shared progress dashboard showing expected PSA drop from 4.1 to under 2.0 within 28 days. Robert reviewed each line while Sarah poured more coffee, cross-checked the pharmacy address against Google Maps, and clicked Accept. He completed the secure Stripe transaction with a single OTP on his phone; the funds moved instantly into escrow, held safely until he confirmed satisfaction after the 15-day window. “Payment protected,” the confirmation read, and moments later Dr. Vargas dropped the first voice-guided dosing calendar into the chat with a warm note: “Start tomorrow morning, Robert—your team in Madrid, Singapore, and Mumbai is right here with you.”
That same afternoon Robert forwarded the updated protocol to his local oncologist at Inova Fairfax via secure patient portal, then sat with Sarah on their backyard patio overlooking the autumn leaves on the trees along Glebe Road. The family discussed the change over dinner that evening—his 16-year-old son Ethan asked specific questions about the CAR-T component after hearing the voice note replayed on speaker, and Robert explained how the Global News Hub had delivered the Oxford breakthrough directly to his Personal Care Team before any US journal had reached his local doctor. By Day 5 of the new protocol Robert’s energy levels, tracked on his Fitbit, rose from an average daily score of 62 to 81; he completed a full 45-minute walk along the Mount Vernon Trail without the fatigue that had plagued him since radiation ended. He sent a voice update from the trail at 7 a.m.: “PSA test this morning came back at 3.4 already—thank you all.” Dr. Chen in Singapore replied first with a translated voice note: “That matches the 68 percent early responders in the Oxford cohort we reviewed together. Add the Singapore-sourced curcumin supplement I recommended last month—available at the Arlington Whole Foods on Wilson Boulevard for $38 per bottle.” Dr. Sharma in Mumbai followed with a voice message confirming the exact bloodwork markers to watch, and the entire team coordinated adjustments in real time inside the group chat.
Week after week the results compounded across every measurable dimension of Robert’s life in Arlington. By Week 3 his PSA had fallen to 1.9, exactly as the Oxford trial data had predicted for patients with his profile, and he returned to his Saturday morning golf games at the Army Navy Country Club in Fairfax without the joint pain that once forced him to quit after nine holes. Sarah noticed the change first during their evening walks along the Potomac River path near their home—Robert’s stride was steady again, and he laughed more freely when talking about the boys’ upcoming college visits. At work in his downtown DC office near the White House, colleagues in the logistics department remarked during the weekly team meeting in the 12th-floor conference room that Robert’s focus during contract negotiations had sharpened, and he closed a $2.4 million deal two weeks ahead of schedule. Even his sleep tracker showed consistent 7.8 hours instead of the broken 5.4 hours he had endured before the protocol update, with the voice-guided relaxation exercises from Dr. Vargas helping him fall asleep within twelve minutes each night.
Robert made the Global News Hub check a non-negotiable morning habit. Every day at 6:45 a.m., while the coffee brewed in his kitchen, he opened the Multime AI app on his phone and scanned the curated health headlines—stories pulled from The Lancet, Nature Medicine, and real-time updates from European and Asian trial centers. On November 12th he spotted a new entry about a Singapore-based Phase II study on combination microbiome therapy for hormone-resistant prostate cases. He shared the article link instantly into the Personal Care Team group chat with a short voice note: “Team, this microbiome angle from Singapore looks promising for my next PSA plateau—Dr. Chen, can you evaluate against my latest labs?” Dr. Chen replied within 40 minutes while it was still evening in Singapore: “Robert, the data overlaps 87 percent with your current biomarkers. I’ve prepared an Offer to add the specific probiotic strain used in the trial—available through the same Arlington compounding pharmacy for an additional $85 per month.” Robert accepted the Offer that same morning, paid securely through Stripe, and escrow held the funds. The probiotic arrived via overnight delivery from the pharmacy on Columbia Pike three days later, and within ten days his next PSA test at Inova Fairfax dropped another 0.7 points to 1.2.
The platform’s escrow system continued protecting every upgrade. When Robert marked the microbiome Offer complete after the full 15-day confirmation window, he uploaded his latest lab report and the daily symptom journal he had kept in the shared template. No issues arose, so escrow released the payment automatically to Dr. Chen on schedule. The entire group chat history—every shared news article from the Global News Hub, every voice note, lab upload, and protocol adjustment—remained securely stored in Robert’s My Account dashboard under Purchased Services, creating a living medical timeline he could reference or share with any future specialist. His local oncologist at Inova Fairfax, during the December follow-up visit in the brightly lit exam room on Gallows Road, reviewed the updated protocol printout Robert brought and noted in the chart: “Patient proactively integrated international trial data via global platform—PSA trajectory now exceeds standard care benchmarks.”
Robert’s proactive habit rippled through his entire Arlington community. His golf partner at Army Navy Country Club, a 54-year-old accountant named Michael who had been struggling with similar prostate markers, asked for details during their Sunday morning round in late November. Robert walked him through the exact steps at the 19th-hole bar overlooking the fairways: open the Multime AI app every morning, scan the Global News Hub for breakthrough headlines, share any relevant article straight into your Personal Care Team chat, and let your matched doctors evaluate and upgrade the protocol in real time. Michael signed up that same afternoon on his phone while still at the clubhouse, selected the same Oncology and Lifestyle Medicine interests, and within 24 hours the smart matching engine delivered his own team of specialists in Barcelona and Seoul. By January 2026 Michael reported his PSA had dropped from 5.8 to 2.4 after integrating a new combination therapy first flagged in the Global News Hub, exactly as Robert had experienced.
Sarah, Robert’s wife, began using the same daily Global News Hub routine for her own preventive care after watching his transformation. On a quiet December evening in their living room, while the boys did homework at the dining table, she opened the app and shared a new Lancet article about a UK-based breast cancer prevention protocol with her own Personal Care Team—matched earlier through the platform’s engine because of her family history. Her Madrid-based preventive medicine doctor responded with an Offer within an hour, and Sarah accepted the low-dose aspirin-plus-lifestyle adjustment plan for $95, paid securely through Stripe with escrow protection. Within six weeks her inflammatory markers, tested at the same Inova lab Robert used, fell 34 percent, and she joined Robert on longer walks along the Potomac without the fatigue she had carried for years.
By March 2026 Robert’s story had become a quiet legend among his Arlington neighbors and DC colleagues. His PSA remained stable at 0.9 for four straight months, his energy allowed him to coach his younger son’s baseball team every Saturday at the local park on Glebe Road, and his work performance review at the logistics firm praised his “sharper strategic thinking and zero sick days.” The My Account dashboard showed 14 completed Offers, every one triggered by a Global News Hub article shared into the group chat and turned into actionable upgrades by his international team. Notifications from the Multime AI app arrived reliably each morning with the latest headlines, ensuring Robert never missed a breakthrough that could affect his care. The smart matching engine continued surfacing new specialists whenever his uploaded lab data suggested fresh overlaps, and the Personal Care Team group chat had become the central nervous system of his health—every Oxford trial, Singapore microbiome study, or Mumbai immunotherapy update discussed, evaluated, and integrated within hours rather than months.
One sunny April afternoon Robert stood on the 9th green at Army Navy Country Club with Michael, watching their balls roll toward the pin while the spring breeze carried the scent of freshly cut grass. He recorded a short voice note in the group chat for his entire team: “Doctors, the Global News Hub just flagged a new combination from a Tokyo trial that could extend my remission window another 24 months—ready when you are.” Dr. Vargas replied instantly with a voice note that played through the app while Robert lined up his putt: “Already reviewed the Tokyo data against your latest labs, Robert—Offer coming in 30 minutes. Your team in Madrid, Singapore, and Mumbai has your back.” Robert sank the putt, smiled at Michael, and said simply, “This is how we stay ahead now.” The platform had not only delivered world-class care into his Arlington home but had given him and everyone around him the daily habit of turning global breakthroughs into personal victories—proving that the most powerful medicine begins the moment you open the Global News Hub, share what you find, and let your Personal Care Team turn tomorrow’s headlines into today’s healing. Robert Thompson’s life in Virginia now moved with the calm confidence of a man who would never again fall behind.
Detailed Guide To Create Buyer Account On StrongBody AI
To start, create a Buyer account on StrongBody AI. Guide: 1. Access website. 2. Click “Sign Up”. 3. Enter email, password. 4. Confirm OTP email. 5. Select interests (yoga, cardiology), system matching sends notifications. 6. Browse and transact. Register now for free initial consultation!
Overview of StrongBody AI
StrongBody AI is a platform connecting services and products in the fields of health, proactive health care, and mental health, operating at the official and sole address: https://strongbody.ai. The platform connects real doctors, real pharmacists, and real proactive health care experts (sellers) with users (buyers) worldwide, allowing sellers to provide remote/on-site consultations, online training, sell related products, post blogs to build credibility, and proactively contact potential customers via Active Message. Buyers can send requests, place orders, receive offers, and build personal care teams. The platform automatically matches based on expertise, supports payments via Stripe/Paypal (over 200 countries). With tens of millions of users from the US, UK, EU, Canada, and others, the platform generates thousands of daily requests, helping sellers reach high-income customers and buyers easily find suitable real experts.
Operating Model and Capabilities
Not a scheduling platform
StrongBody AI is where sellers receive requests from buyers, proactively send offers, conduct direct transactions via chat, offer acceptance, and payment. This pioneering feature provides initiative and maximum convenience for both sides, suitable for real-world health care transactions – something no other platform offers.
Not a medical tool / AI
StrongBody AI is a human connection platform, enabling users to connect with real, verified healthcare professionals who hold valid qualifications and proven professional experience from countries around the world.
All consultations and information exchanges take place directly between users and real human experts, via B-Messenger chat or third-party communication tools such as Telegram, Zoom, or phone calls.
StrongBody AI only facilitates connections, payment processing, and comparison tools; it does not interfere in consultation content, professional judgment, medical decisions, or service delivery. All healthcare-related discussions and decisions are made exclusively between users and real licensed professionals.
User Base
StrongBody AI serves tens of millions of members from the US, UK, EU, Canada, Australia, Vietnam, Brazil, India, and many other countries (including extended networks such as Ghana and Kenya). Tens of thousands of new users register daily in buyer and seller roles, forming a global network of real service providers and real users.
Secure Payments
The platform integrates Stripe and PayPal, supporting more than 50 currencies. StrongBody AI does not store card information; all payment data is securely handled by Stripe or PayPal with OTP verification. Sellers can withdraw funds (except currency conversion fees) within 30 minutes to their real bank accounts. Platform fees are 20% for sellers and 10% for buyers (clearly displayed in service pricing).
Limitations of Liability
StrongBody AI acts solely as an intermediary connection platform and does not participate in or take responsibility for consultation content, service or product quality, medical decisions, or agreements made between buyers and sellers.
All consultations, guidance, and healthcare-related decisions are carried out exclusively between buyers and real human professionals. StrongBody AI is not a medical provider and does not guarantee treatment outcomes.
Benefits
For sellers:
Access high-income global customers (US, EU, etc.), increase income without marketing or technical expertise, build a personal brand, monetize spare time, and contribute professional value to global community health as real experts serving real users.
For buyers:
Access a wide selection of reputable real professionals at reasonable costs, avoid long waiting times, easily find suitable experts, benefit from secure payments, and overcome language barriers.
AI Disclaimer
The term “AI” in StrongBody AI refers to the use of artificial intelligence technologies for platform optimization purposes only, including user matching, service recommendations, content support, language translation, and workflow automation.
StrongBody AI does not use artificial intelligence to provide medical diagnosis, medical advice, treatment decisions, or clinical judgment.
Artificial intelligence on the platform does not replace licensed healthcare professionals and does not participate in medical decision-making.
